H.R. 1672

119th Congress

In Committee

Maintaining Investments in New Innovation Act

Sponsored byDemocrat:Rep. Davis, Donald G. [D-NC-1]NC· Introduced 27 February 2025
Open on Congress.gov

46

Cosponsors

4

Actions

0

Amendments

2

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

27 February 2025·1 year ago

Summary

Introduced in House · Updated 26 March 2025

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Timeline

4 actions

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    27 February 2025 · IntroReferral

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    27 February 2025 · IntroReferral

  3. Introduced in House

    27 February 2025 · IntroReferral

  4. Introduced in House

    27 February 2025 · IntroReferral

Sponsorship

46 cosponsors

Sponsor

Democrat:Rep. Davis, Donald G. [D-NC-1]NC

Cosponsors

  • Democrat511%
  • Republican4189%

Classification

Policy area

Health

Legislative subjects

GeneticsMedicarePrescription drugs

Committees

2

  • Energy and Commerce Committee

    House · Standing

    • Referred To27 Feb 2025

  • Ways and Means Committee

    House · Standing

    • Referred To27 Feb 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 13 on 27 February 2025 to 46 on 25 June 2026.

Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.